期刊文献+

中国肥厚型心肌病患者心脏型肌球蛋白结合蛋白C基因突变特点分析 被引量:1

Analysis the Genotype of Cardiac Myosin-binding Protein C Gene Associated with Chinese Hypertrophic Cardiomyopathy Patients
原文传递
导出
摘要 目的观察中国肥厚型心肌病(HCM)患者心脏型肌球蛋白结合蛋白C基因(MYBPC3)突变的特点。方法在100例中国HCM患者中对MYBPC3基因的所有外显子及其侧翼内含子序列进行基因扫描,聚合酶链反应(PCR)扩增目的片段,双脱氧末段终止法测序。分析国人HCM患者基因突变的特点。结果 100例HCM患者中,10例患者携带9种MYBPC3基因突变,5种为错义突变,1种为剪接位点突变,1种为插入突变,2种为缺失突变。结论 MYBPC3基因是中国HCM人群的常见致病基因,并且MYBPC3基因突变形式多种多样,这是其主要的突变特点之一。 Objective To describe the features of cardiac myosin-binding protein C gene (MYBPC3) mutations associated with hypertrophic cardiomyopathy. Methods A systematic mutation screening of the whole exons and the adjacent introns of MYBPC3 gene was performed in 100 unrelated Chinese adult patients with HCM using direct DNA sequencing. Results Ten cases carried 9 mutations was identified in 100 isolated pa- tients with HCM, including 5 missense mutations,1 splice-site mutation, 1 insertion mutation and 2 deletion mutations. Conclusion MYBPC3 was the predominant HCM-causing gene in Chinese, and various mutation types were identified, which was one of the most distinct features of MYBPC3 genotype.
出处 《中国分子心脏病学杂志》 CAS 2013年第2期497-500,共4页 Molecular Cardiology of China
基金 国家自然基金面上项目(81070100)
关键词 肥厚型心肌病 MYBPC3基因 突变 Hypertrophic Cardiomyopathy MYBPC3 Mutation
  • 相关文献

参考文献12

  • 1Marian AJ. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J CIi" Invest. 2010; 40:360-369.
  • 2Konno T, Chang S, Seidman JG, et a!. Genetics of hypertrophic cardiomyopathy. Curl' Opin Cardiol. 2010; 25(3):205-209.
  • 3Geisterfer-Lowrance AA, Kass S, Tanigawa G, et a!. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990; 62:999-1006.
  • 4Niimura, H, Bachinski LL, Sangwatanaroj S, et a!. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med1998; 338: 1248-1257.
  • 5Richard P, Charron P, Carrier L, et a!. Hypertrophic cardiomyopathy distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003; 107:2227-2232.
  • 6Winegrad S. Cardiac Myosin Binding Protein e. Circ Res. 1999; 84: 1117- 1126.
  • 7Yasuda M, Koshida S, Sato N, et al. Complete primary structure of chicken cardiac C-protein (MyBP-C) and its expression in developing striated muscle. J Mol Cell Cardiol. 1995; 27:2275-2286.
  • 8Okagaki T, Weber FE, Fischman DA, et a!. The major myosin binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH?terminal, immuno-globulin C2 repeat. J Cell Bioi. 1993; 123:619-626.
  • 9Swan RC, Fischman DA. Electron microscopy ofc-protein molecules from chicken skeletal muscle. J Muscle Res Cell Mottl. 1986; 7: 160-166.
  • 10Hartzell C, Sale We. Structure of C-protein purified from cardiac muscle. J Cell BioI. 1985; 100:208-215.

同被引文献10

  • 1Marian AJ. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin lnvest. 2010; 40:360-369 2.
  • 2Konno T, Chang S, Seidman JG, et al. Genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol. 2010; 25(3):205-209.
  • 3McKenna WJ. Report of the 1995 World Health Organization / International Society and Federation of Cardiology: Task Force on the definition and classification of cardiomyopathies. Circulation. 1996; 93:841-842 5.
  • 4Mayosi B, Watkins H. The diagnosis of familial hypertrophic cardiomyopathy. European Heart JournaL 1998;19:1276-1278 6.
  • 5Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl JMed 2003; 348:295-303.
  • 6Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic eardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990; 62:999-1006 8.
  • 7Niimura, H, Bachinski LL, Sangwatanaroj S, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. NEngl JMed. 1998; 338:1248-1257 9.
  • 8Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003; 107:2227-2232 10.
  • 9Schlossarek S, Mearini G, Carrier L. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: Mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2011 ; 50 (4): 613-618 11.
  • 10Winegrad S. Cardiac Myosin Binding Protein C. Circ Res. 1999; 84:1117-1126.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部